REAL vs. IMRX

Last updated Jun 13, 2026

REAL (The RealReal, Inc.) and IMRX (Immuneering Corporation) are both stocks. REAL operates in Specialty Retail (Consumer Cyclical), while IMRX operates in Biotechnology (Healthcare). Over the past 3 years, REAL returned 81.13%/yr vs -24.01%/yr for IMRX. At a 0.20 correlation, their price movements are largely independent.

Performance

REAL vs. IMRX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The RealReal, Inc. (REAL) and Immuneering Corporation (IMRX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

The year-to-date returns for both stocks are quite close, with REAL having a -34.85% return and IMRX slightly lower at -36.32%.

REAL

• 1D: 4.47%
• 1M: 9.25%
• YTD: -34.85%
• 6M: -28.31%
• 1Y: 92.87%
• 3Y*: 81.13%
• 5Y*: -12.76%
• 10Y*: —

IMRX

• 1D: 1.70%
• 1M: -22.12%
• YTD: -36.32%
• 6M: -31.09%
• 1Y: 113.78%
• 3Y*: -24.01%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

REAL vs. IMRX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
REAL The RealReal, Inc.	-34.85%	44.37%	443.78%	60.80%	-89.23%	-31.91%
IMRX Immuneering Corporation	-36.32%	199.09%	-70.07%	51.55%	-70.01%	-17.08%

Correlation

The correlation between REAL and IMRX is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (All Time) Calculated using the full available price history since Jul 30, 2021	0.20

The correlation between REAL and IMRX shifts across timeframes, from 0.10 (1 year) to 0.20 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap REAL : $3.23B IMRX : $270.92M
EPS REAL : -$0.22 IMRX : -$293.00
Total Revenue (TTM) REAL : $722.53M IMRX : $0.00
Gross Profit (TTM) REAL : $529.97M IMRX : -$698.89K
EBITDA (TTM) REAL : -$60.20M IMRX : -$15.38B

Return for Risk

REAL vs. IMRX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

REAL

REAL Risk / Return Rank: 76
REAL Sharpe Ratio Rank: 78
REAL Sortino Ratio Rank: 81
REAL Omega Ratio Rank: 76
REAL Calmar Ratio Rank: 74
REAL Martin Ratio Rank: 73

IMRX

IMRX Risk / Return Rank: 75
IMRX Sharpe Ratio Rank: 72
IMRX Sortino Ratio Rank: 78
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 76
IMRX Martin Ratio Rank: 70

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

REAL vs. IMRX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for The RealReal, Inc. (REAL) and Immuneering Corporation (IMRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	REAL	IMRX	Difference
Sharpe ratio: Return per unit of total volatility	1.21	0.92	+0.28
Sortino ratio: Return per unit of downside risk	2.22	2.05	+0.17
Omega ratio: Gain probability vs. loss probability	1.25	1.29	-0.04
Calmar ratio: Return relative to maximum drawdown	1.80	1.98	-0.19
Martin ratio: Return relative to average drawdown	3.95	3.30	+0.64

REAL vs. IMRX - Sharpe Ratio Comparison

The current REAL Sharpe Ratio is 1.21, which is higher than the IMRX Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of REAL and IMRX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

REAL vs. IMRX - Drawdown Comparison

The maximum REAL drawdown since its inception was -96.44%, roughly equal to the maximum IMRX drawdown of -96.86%. Use the drawdown chart below to compare losses from any high point for REAL and IMRX.

Drawdown Indicators

	REAL	IMRX	Difference
Max Drawdown Largest peak-to-trough decline	-96.44%	-96.86%	+0.42%
Max Drawdown (1Y) Largest decline over 1 year	-51.95%	-57.67%	+5.72%
Max Drawdown (3Y) Largest decline over 3 years	-57.16%	-90.98%	+33.82%
Max Drawdown (5Y) Largest decline over 5 years	-95.42%	—	—
Current Drawdown Current decline from peak	-64.43%	-87.24%	+22.81%
Average Drawdown Average peak-to-trough decline	-67.33%	-77.61%	+10.28%
Ulcer Index Depth and duration of drawdowns from previous peaks	23.62%	34.56%	-10.94%

Volatility

REAL vs. IMRX - Volatility Comparison

The current volatility for The RealReal, Inc. (REAL) is 17.24%, while Immuneering Corporation (IMRX) has a volatility of 33.75%. This indicates that REAL experiences smaller price fluctuations and is considered to be less risky than IMRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	REAL	IMRX	Difference
Volatility (1M) Calculated over the trailing 1-month period	17.24%	33.75%	-16.51%
Volatility (6M) Calculated over the trailing 6-month period	48.58%	79.00%	-30.42%
Volatility (1Y) Calculated over the trailing 1-year period	77.43%	124.22%	-46.79%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	97.37%	114.45%	-17.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	93.85%	114.45%	-20.60%

Dividends

REAL vs. IMRX - Dividend Comparison

Neither REAL nor IMRX has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both REAL and IMRX in my portfolio?

REAL and IMRX have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, REAL or IMRX?

IMRX has higher volatility (33.75%) compared to REAL (17.24%). In terms of maximum drawdown, REAL dropped -96.44% vs IMRX's -96.86%.

Which has better risk-adjusted returns?

REAL currently has the higher Sharpe Ratio (1.21 vs 0.92), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.